ALL RNA species in eukaryotic cells are subject to turnover, which plays several roles in yeast cells. First, the differential degradation of messenger RNA (mRNAs) can play an important role in setting the basal level of mRNA expression and how that mRNA level is modulated by environmental stimuli. Second, numerous quality control systems degrade aberrant transfer RNA (tRNAs) and ribosomal RNA (rRNAs), as well as aberrant mRNAs, which might otherwise encode a defective protein product. Third, RNA degradation removes the by-products of gene expression, including excised introns and other RNA pieces released during RNA processing. Finally, RNA degradation mechanisms functions in removing intergenic, intragenic, promoter-associated, and antisense RNAs that arise either as regulatory RNAs or transcriptional noise.

 Here I review our understanding of the pathways and nucleases of RNA turnover by considering the different classes of RNAs and how they are degraded. Three common themes emerge from this review. First, most RNA degradation mechanisms funnel RNAs to the cytoplasmic [Xrn1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003141) or nuclear [Rat1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005574) 5′ to 3′ nucleases, or to the exosome, which is a conserved cytoplasmic and nuclear complex with both 3′ to 5′ exonuclease activities and an endonuclease cleavage site. Second, where examined, all RNAs are subject to quality control systems where nonfunctional RNAs are more rapidly degraded. Third, the RNA pathways are modulated by environmental inputs and interact with other cellular processes including translation, RNA processing, transcription, and stress responses.

Degradation of mRNA {#s1}
===================

Cytoplasmic turnover of mRNA {#s2}
----------------------------

Cytoplasmic degradation of yeast mRNAs occurs by two general pathways, both of which are initiated by shortening of the 3′ poly(A) tail in a process referred to as deadenylation ([@bib222]; [@bib72]) ([Figure 1A](#fig1){ref-type="fig"}). Deadenylation in yeast is carried out by the [Pan2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003062)/[Pan3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001508) complex as well as the by [Ccr4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000019)/[Pop2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005335)/Not complex ([@bib33]; [@bib309]). Following deadenylation, mRNAs can be subjected to 3′ to 5′ degradation by the exosome ([@bib6]). More commonly, mRNAs are decapped by the [Dcp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005509)/[Dcp2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005062) decapping enzyme and then subjected to 5′ to 3′ degradation by [Xrn1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003141) ([@bib150]; [@bib227], 1995; [@bib90]; [@bib314]; [@bib282]).

![(A) General mRNA decay pathways. (B) Specialized mRNA decay pathways.](671fig1){#fig1}

Yeast also contain specialized mRNA decay pathways that act in response to aberrancies in translation ([Figure 1B](#fig1){ref-type="fig"}). In these cases, mRNAs can be subject to either deadenylation independent decapping ([@bib223]), rapid 3′ to 5′ degradation ([@bib319]), or endonuclease cleavage ([@bib85]). The available evidence suggests that these specialized mechanisms function primarily on aberrant mRNAs, although the nonsense-mediated decay (NMD) pathway does degrade a pool of "normal" mRNAs (see section on *mRNA Quality Control Pathways*).

Several observations suggest that, at least during mid-log growth phase, decapping is the predominant pathway of mRNA degradation. First, strains lacking the decapping enzyme grow very slowly or are lethal in some strain backgrounds ([@bib19]; [@bib90]; [@bib116]), while strains defective in cytoplasmic 3′ to 5′ mRNA degradation grow relatively normally ([@bib6]; [@bib116]). Second, strains defective in decapping or 5′ to 3′ degradation show changes in both the steady-state levels and decay rates of many mRNAs ([@bib19]; [@bib137]). Finally, the genome-wide mapping of endonuclease sites in mRNAs has revealed that few yeast mRNAs are subject to endonucleolytic degradation (Y. Harigaya and R. Parker, unpublished data). However, it should be noted that 3′ to 5′ degradation of mRNAs is just slightly slower than decapping. For example, for the [PGK1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000605) and [MFA2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005089) mRNAs, computational analysis of experimental data has indicated that 3′ to 5′ decay is 1.5 and 6 times slower than decapping, respectively ([@bib42]).

As assessed by a variety of different methods ([@bib240]; [@bib229]), the degradation rates of individual mRNAs can vary by over an order of magnitude. This was first observed in decay rate measurements of groups of mRNAs ([@bib141]; [@bib33]) and has now been confirmed by multiple genome-wide studies of mRNA decay rates ([@bib327]; [@bib125]). The decay rates of mRNAs are somewhat clustered by the function of the encoded protein ([@bib141]; [@bib125]; [@bib20]). Differences in the decay rates of individual mRNAs can arise by differences in deadenylation rates, decapping rates, or the rates of 3′ to 5′ degradation ([@bib42]; [@bib20]). For example, the [MFA2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005089) mRNA (*t*~1/2~ = 3′--4′) differs from the relatively stable PGK1 mRNA (*t*~1/2~ = 30′--45′) by having faster rates of deadenylation (15 adenosines/min compared to 3 adenosines/min), decapping (0.0077 sec^−1^ compared to 0.000462 sec^−1^) and 3′ to 5′ degradation (0.0012 sec^−1^ compared to 0.0003 sec^−1^) ([@bib42]). Thus, to understand differential control of mRNA decay rates, one must consider the processes of deadenylation, decapping, and 3′ to 5′ degradation and how they are regulated.

Deadenylation {#s3}
-------------

Two enzyme complexes catalyze poly(A) shortening ([Table 1](#t1){ref-type="table"}). The predominant deadenylase is the [Ccr4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000019)/[Pop2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005335)/Not complex ([@bib70]; [@bib309]). This large complex consists of two active 3′ to 5′ exonucleases ([Ccr4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000019) and [Pop2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005335)/[Caf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005335)) and includes the [Not1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000689), [Not2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002324), [Not3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001300), [Not4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000870), [Not5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006276), [Caf40](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005232), and [Caf130](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003366) proteins ([@bib77]). In yeast, at least during mid-log growth, the major deadenylase in this complex is the [Ccr4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000019) protein, a member of the ExoIII nuclease family, since mutations in the active site of this enzyme give defects in deadenylation similar to the [ccr4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000019)Δ strain ([@bib53]; [@bib310]). [Ccr4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000019) also interacts directly with the [Pop2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005335) protein through a leucine-rich-repeat region ([@bib59]).

###### General factors involved in mRNA deadenylation

  Factor                  Function                                                                                                                                                                                                                       References
  ----------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ -----------------------------------------------------------------
  Ccr4/Pop2/Not complex   Major mRNA deadenylaseCcr4 critical catalytic subunit, ExoIII family memberPop2: second catalytic subunit, RNaseD family memberNot1: large scaffolding proteinNot2--5, Caf130, Caf40: accessory proteins of unknown function   [@bib70]; [@bib309], [@bib310]); [@bib53]
  Pan2/Pan3 complex       Additional mRNA deadenylasePrimarily functions in initial trimming of poly(A) tailPan2: catalytic subunit; RNaseD family memberInteracts with and stimulated by Pab1Pan3: regulatory subunit                                   [@bib34]; [@bib25]; [@bib33]
  Tpa1                    Prolyl 4-hydroxylaseBinds poly(A)Interacts with eRF1 and eRF3Required for normal deadenylation and translation termination                                                                                                     [@bib168]; [@bib140]; [@bib170]
  Pab1                    Major poly(A)-binding proteinInhibits Ccr4 deadenylaseStimulates Pan2/Pan3 complexMay interact with eRF3 to affect deadenylationCouples deadenylation to decapping                                                             [@bib44]; [@bib25]; [@bib63]; [@bib310]; Hosada *et al.* (2003)
  eRF3 (Sup35)            Subunit of translation termination complex                                                                                                                                                                                     Hosada *et al.* (2003); [@bib107]
                          Interacts with Pab1 and thereby may influence deadenylation rates                                                                                                                                                              
  Rpb4/Rpb7               Two subunits of RNA polymerase II                                                                                                                                                                                              [@bib195], [@bib196])
                          Required for normal rates of deadenylation                                                                                                                                                                                     
                          May exit from nucleus as part of mRNP to affect cytoplasmic deadenylation                                                                                                                                                      

The [Pop2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005335)/[Caf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005335) protein, a member of the RNaseD family, is a second exonuclease in the [Ccr4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000019)/[Pop2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005335)/Not complex ([@bib305]). Despite the presence of noncanonical residues in its active site, one report describes [Pop2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005335) purified from bacteria as having 3′ exonuclease *in vitro* ([@bib305]). However, all of the catalytic activity of [Ccr4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000019)/[Pop2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005335) complexes purified from yeast is dependent on the [Ccr4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000019) active site, suggesting that [Ccr4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000019) is the critical active deadenylase ([@bib119]). Strains lacking [Pop2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005335)/[Caf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005335) show a defect in deadenylation, but this is due to [Pop2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005335) interacting with and promoting [Ccr4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000019) function since mutations in the active site of [Pop2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005335) do not alter deadenylation of reporter mRNAs and overexpression of [Ccr4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000019) suppresses the deadenylation defects seen in a [pop2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005335)Δ strain ([@bib310]; [@bib323]). Since [Pop2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005335)/[Caf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005335) has catalytic activity and [Pop2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005335) orthologs in other organisms play catalytic roles in deadenylation ([@bib117]), it remains a formal possibility that [Pop2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005335) may function as a deadenylase under some conditions or for some mRNAs.

The roles of the Not, [Caf40](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005232), and [Caf130](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003366) proteins in deadenylation are not yet clear. One possibility is that they adapt the deadenylase complex to different mRNAs through the action of regulatory proteins. Consistent with this possibility, defects in some of the Not proteins can affect deadenylation of specific mRNAs ([@bib310]). An alternative is that the Not and Caf accessory proteins play roles in other functions of the [Ccr4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000019)/[Pop2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005335)/Not complex, which has been suggested to have roles in transcription initiation and elongation ([@bib76]; [@bib285]; [@bib249]).

A second deadenylase complex consists of the [Pan2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003062) and [Pan3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001508) proteins, with [Pan2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003062), a RNaseD family member, being the catalytic subunit ([@bib25]). [Pan2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003062) and [Ccr4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000019) appear to be the only major deadenylases since [pan2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003062)Δ [ccr4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000019)Δ strains are slow growing and show no deadenylation of reporter mRNAs ([@bib309]). The activity of [Pan2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003062) is promoted by [Pab1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000967) ([@bib25]), while [Pab1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000967) appears to inhibit the action of the [Ccr4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000019) complex ([@bib310]). This suggests that mRNAs with [Pab1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000967) bound to the poly(A) tail will be resistant to deadenylation by [Ccr4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000019)/[Pop2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005335) but will be substrates for [Pan2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003062)/[Pan3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001508). Thus, the specific deadenylase active on an mRNA will be influenced by the nature of the protein complex on its 3′ poly(A) tail.

The [Pan2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003062)/[Pan3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001508) and [Ccr4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000019)/[Pop2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005335)/Not complexes appear to function in a temporal manner on most mRNAs with [Pan2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003062)/[Pan3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001508) first acting to shorten the nascent poly(A) tail from ∼90 residues to ∼65, although this can vary a bit between different mRNAs ([@bib33]). This step appears to happen quickly since the poly(A) tail lengths longer than 70 residues are typically not observed in yeast cells unless [Pan2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003062) is inactive ([@bib33]). This implies that there is a difference between the accessibility of the 0--65 A residues of the poly(A) tail and the 3′-most 25 nucleotides. Since [Pab1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000967) promotes [Pan2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003062) activity, one model is that this deadenylation reflects [Pab1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000967) bound to the first ∼65 residues of the A tail, but the 3′ most region is exposed and thereby rapidly deadenylated by [Pan2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003062). Since [pan2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003062)Δ strains show relatively normal deadenylation of reporter mRNAs ([@bib309]), [Ccr4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000019) then appears to be responsible for the continued deadenylation of the mRNA. Since the [Ccr4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000019) complex is inhibited by [Pab1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000967) ([@bib310]), this phase of deadenylation implies that [Pab1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000967) is at least partially dissociating from the poly(A) tail. However, in strains lacking [Ccr4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000019) activity, the [Pan2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003062) complex can continue to deadenylate mRNAs, although at a slower rate than [Ccr4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000019) ([@bib309]). Interestingly, the [Pan2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003062) complex stalls at an A tail of ∼20--25 residues ([@bib70]; [@bib309]), which might be a length at which the [Pab1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000967) can no longer associate with the mRNA, and therefore [Pan2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003062) activity becomes limited ([@bib309]). Interestingly, once the poly(A) tail reaches an oligo(A) length of 10--12 residues, the mRNA can become a substrate for decapping and for binding of the [Pat1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000673)/[Lsm1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003660)--7 complex at the 3′ end ([@bib297]; [@bib57]), which enhances the rate of decapping. This exchange of the [Pab1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000967) protein for the [Pat1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000673)/[Lsm1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003660)--7 complex is part of the mechanism that allows decapping to be promoted following deadenylation (see below).

### Control of deadenylation: {#s4}

Three types of interactions are known to modulate deadenylation rate, either generally or on specific mRNAs. First, because the [Ccr4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000019) and [Pan2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003062) deadenylases are influenced by the binding of [Pab1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000967) to the poly(A) tail, the rate of deadenylation is influenced by features of the [Pab1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000967)--poly(A) interaction and its dynamics. Because [Pab1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000967)--mRNA interactions are influenced by translation *per se*, this leads to deadenylation being coupled to aspects of translation. Second, key regulators of deadenylation on specific mRNAs are sequence-specific binding proteins that either directly, or indirectly, recruit the deadenylases to the mRNA to accelerate deadenylation. Finally, deadenylation is regulated in response to environmental cues, including stress and nutrient limitations.

On the basis of the biochemical analyses of deadenylases, a working model for understanding how deadenylation is affected by mRNP dynamics is that when [Pab1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000967) is present on the poly(A) tail, the [Ccr4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000019) deadenylase is inhibited and [Pan2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003062) is stimulated, whereas, when [Pab1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000967) dissociates, [Ccr4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000019) deadenylation is accelerated and [Pan2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003062) deadenylation is inhibited. Consistent with this view, self-association of [Pab1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000967) limits its binding to poly(A) and increases [Ccr4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000019)-dependent deadenylation ([@bib281]). Moreover, strains defective in [Pab1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000967) show a defect in the initial rapid [Pan2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003062)-dependent poly(A) shortening ([@bib44]; [@bib220]; [@bib281]).

This model suggests that some of the effects of translation on deadenylation can be understood by their effects on [Pab1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000967) binding the poly(A) tail. For example, defects in translation initiation caused by a poor AUG context, a stem loop in the 5′ UTR, or mutations in translation initiation factors can increase the rates of deadenylation of yeast mRNAs ([@bib228]; [@bib266]). One possibility is that defects in translation initiation either directly or indirectly destabilize [Pab1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000967) binding the poly(A) tail. Note that this model also predicts that [Pan2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003062)-mediated deadenylation would be compromised by decreases in translation initiation. Surprisingly, in temperature-sensitive [eIF4E](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005499) strains, deadenylation of the [Gal1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000224) mRNA increases even in a *[ccr4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000019)Δ* strain, which has been interpreted to suggest that [eIF4E](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005499) can also inhibit [Pan2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003062)-based deadenylation ([@bib185]). However, another possibility is that the "deadenylation" seen in a *[cdc33](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005499)-1 [ccr4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000019)Δ* strain is not due to [Pan2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003062), but may be due to the cytoplasmic exosome (or to an unknown additional deadenylases), which is suggested by the observation that deadenylation is restored in a *[ccr4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000019)Δ [pan2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003062)Δ* strain when [pab1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000967) is mutated (M. Tucker and R. Parker, unpublished observation).

Deadenylation is also affected by aspects of translation termination. For example, premature translation termination accelerates poly(A) shortening as part of the process of NMD (see below and [@bib43]; [@bib219]). This accelerated deadenylation may be a consequence of NMD leading to repression of translation and/or to dissociation of [Pab1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000967) from the mRNA, since decapping triggered by NMD is independent of the poly(A) tail ([@bib223]). Similarly, the [Tpa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000851) protein, a proline hydroxylase that binds poly(A) and interacts with translation termination factors, can influence the rate of deadenylation ([@bib168]; [@bib140]).

The coupling of translation termination to deadenylation has been suggested to occur through direct interactions of the translation termination factor [eRF3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002579) with [Pab1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000967) ([@bib63]). This interaction appears to influence mRNA deadenylation since overexpression or deletion of the N-terminal domain of [eRF3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002579), where [Pab1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000967) interacts, leads to defects in deadenylation and mRNA decay ([@bib172]; [@bib107]). Since this effect seems to be primarily on the [Ccr4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000019) deadenylase ([@bib107]), one possibility is that [eRF3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002579)--[Pab1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000967) interactions during translation termination transiently dissociate [Pab1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000967) from the poly(A) tail and increase deadenylation. However, it is important to note that translation termination is not required for deadenylation since mRNAs that never initiate translation due to stem-loop structures in their 5′ UTRs still deadenylate rapidly ([@bib18]; [@bib228]).

Deadenylation also appears to be coupled to the process of transcription. The [Rpb4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003676) and [Rpb7](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002812) subunits of RNA polymerase II are required for optimal deadenylation rates of yeast mRNAs ([@bib195], [@bib196]), and this has been proposed to occur by [Rpb4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003676) and [Rbp7](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002812) loading on the mRNA during transcription to regulate cytoplasmic function (see *Future* *Perspectives*).

### Control of deadenylation by mRNA-specific features: {#s5}

There are now several examples of specific proteins that bind mRNAs in a sequence-specific manner to control deadenylation. Moreover, in many other cases, 3′ UTR elements modulate the poly(A) tail length, presumably by deadenylation, and identify a broad role of deadenylation regulation in gene expression ([@bib20]). For example, the six members of the Puf protein family bind to specific-sequence 3′ UTR elements and regulate ∼10% of the yeast transcriptome ([@bib233]; [@bib114]; [@bib342]). In yeast, the [Puf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003851), [Puf3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003936), [Puf4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002982), and [Puf5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003146) proteins have all been shown to promote deadenylation and degradation of specific subsets of yeast mRNAs ([@bib233]; [@bib290]; [@bib311]). Mechanistic studies have demonstrated that [Puf5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003146) promotes deadenylation at least in part by direct interaction with [Pop2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005335) and thereby recruitment of the [Ccr4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000019) deadenylase ([@bib118], [@bib119]), although Puf proteins may also recruit the deadenylase complexes through other interactions. In addition, Puf proteins can also repress translation independently of deadenylation and therefore might also promote deadenylation indirectly ([@bib58]).

Other sequence-specific regulators of deadenylation include the [Vts1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005886) protein, which binds to a subset of yeast mRNAs through a specific stem-loop structure ([@bib12]) and recruits the [Ccr4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000019)/[Pop2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005335) deadenylase ([@bib253]). Similarly, the [Cth1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002558) and [Cth2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004126) proteins are zinc-finger RNA-binding proteins that regulate the deadenylation of a subset of mRNAs, perhaps through interactions with [Dhh1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002319) that interacts with [Pop2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005335) ([@bib248]). One anticipates that a growing set of mRNA-specific binding proteins will regulate deadenylation either by direct recruitment of the deadenylase complexes or by inhibiting translation initiation and thereby indirectly promoting deadenylation.

### Environmental control of deadenylation: {#s6}

Deadenylation is also regulated on a global scale in response to environmental cues. For example, a variety of different stresses lead to a general inhibition of both [Ccr4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000019) and [Pan2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003062) deadenylation ([@bib142]). Similar results occur in mammalian cells, suggesting that inhibition of deadenylation is a conserved aspect of the stress response ([@bib122], [@bib123]). Inhibition of deadenylation during stress does not seem to require mRNAs to assemble in stress granules or P-bodies (see below), since deadenylation is still inhibited by stress in the presence of cyclohexmide ([@bib142]), which prevents the formation of stress granules and P-bodies ([@bib277]; [@bib37]). Deadenylation is also inhibited during stress. Since the stress response often leads to a global decrease in translation initiation, a general inhibition of deadenylation might be required to maintain a stable population of mRNAs. Deadenylation can also be reduced for some mRNAs when Hsp70 function is altered, which might mimic a stress response, although the basis or generality of this effect has not been determined ([@bib92]).

Normal rates of deadenylation also appear to be dependent on the activity of the [Pkh1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002898) and [Pkh2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005460) kinases, which are activated by sphingolipids ([@bib200]). This suggests that aspects of mRNA metabolism are modulated in response to lipid signaling. This interpretation is also supported by the observation that, during heat stress, the formation of P-bodies, which are cytoplasmic mRNP aggregates of untranslating mRNAs, in conjunction with the mRNA decapping machinery (see below), requires sphingolipid synthesis, and exogenous phytosphingosine can stimulate P-body formation ([@bib65]). Interestingly, the effect of [Pkh1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002898) and [Pkh2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005460) on deadenylation rates is observed only in synthetic media, suggesting that this regulation is an integrative readout of both lipid and nutrient availability ([@bib200]). An important area of future work will be to understand how deadenylation is regulated both globally and on specific mRNAs in response to environmental cues.

mRNA decapping {#s7}
--------------

### Nucleases of decapping and 5′ to 3′ degradation: {#s8}

mRNA decapping is carried out by a complex of the [Dcp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005509) and [Dcp2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005062) proteins and is influenced by several other factors ([Table 2](#t2){ref-type="table"}). [Dcp2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005062) is the catalytic subunit and is a member of the Nudix family of pyrophosphatases ([@bib314]). [Dcp2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005062) cleaves the cap structure to release m7GDP and a 5′ monophosphate mRNA ([@bib276]). [Dcp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005509) is an EVH family protein ([@bib274]) that interacts with [Dcp2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005062) to promote its catalytic activity ([@bib79]; [@bib276]). The first 300 amino acids of [Dcp2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005062) are sufficient to promote decapping ([@bib90]) and fold into a two-domain structure wherein the N-terminal domain interacts with [Dcp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005509) and the Nudix domain is present in the C-terminal domain (residues 100--245) ([@bib275], [@bib276]). [Dcp2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005062) has a conserved region between 245 and 286, which contains binding sites for the [Edc3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000741) protein and possibly other decapping activators ([@bib132]). Yeast [Dcp2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005062) has an extended C-terminal region that is not required for general mRNA decapping. Since [Dcp2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005062) can shuttle into the nucleus ([@bib126]) and this region has sites that can enhance transcription ([@bib112]), one possibility is that this region plays some role in controlling transcription ([@bib273]).

###### Decapping and 5′ → 3′ exonuclease factors

  Factor                                            Function                                                                                                                                                                                                                                                                                                                           References
  ------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------
  Dcp1/Dcp2                                         mRNA decapping enzymeDcp2: catalytic subunit: Nudix family memberReleases m7GDP and 5′p-RNADcp1: stimulatory subunit, Evh1/WH1 family memberBlocked by eIF4E bound to cap                                                                                                                                                          [@bib267]; [@bib274], [@bib276]); [@bib79]
  Xrn1                                              Major cytoplasmic 5′ to 3′ exonucleaseProcessive and requires 5′ monophosphateStimulated by Dcs1/Dcs2                                                                                                                                                                                                                              [@bib169]; [@bib247]; [@bib315]; [@bib208];
  Dcs1 (DcpS)/Dcs2                                  mRNA decapping enzymes with preference for short RNAs                                                                                                                                                                                                                                                                              [@bib190]; [@bib158]
                                                    Releases m7Gp and ppN−                                                                                                                                                                                                                                                                                                             
                                                    Cleaves m7GDP produced by Dcp1/Dcp2 to m7GMP and P                                                                                                                                                                                                                                                                                 
                                                    Can affect stress responses                                                                                                                                                                                                                                                                                                        
  Rat1                                              Major nuclear 5′ to 3′ nuclease                                                                                                                                                                                                                                                                                                    [@bib160]; [@bib350]
                                                    Paralog of Xrn1                                                                                                                                                                                                                                                                                                                    
                                                    Functions in nuclear RNA processing and decay                                                                                                                                                                                                                                                                                      
  Rai1                                              Interacts with and stimulates Rat1Contains mRNA cleavage siteReleases m7GpppN− and N−May function in cap quality control                                                                                                                                                                                                           [@bib339]; [@bib350]; [@bib157]
  Pat1                                              Activates general mRNA decappingServes as scaffolding protein for decapping complexesBoth represses translation initiation and stimulates Dcp2Interacts with Lsm1--7 complex and prefers to bind 3′ end of oligoadenylated mRNAPromotes P-body assemblyAfter deadenylation stabilizes 3′ ends to 3′ trimmingTarget of PKA kinase   [@bib30]; [@bib298]; [@bib57]; [@bib245]; [@bib232]; [@bib251]
  Lsm1--7 complex                                   Required for efficient decappingForms heptometric ring complex and binds oligo- or deadenylated mRNAsMay promote Pat1 conformational change to activate Dcp2After deadenylation stabilizes 3′ ends to 3′ trimming                                                                                                                  [@bib26]; [@bib30]; [@bib298]; [@bib57]
  Dhh1                                              Required for efficient decapping of translating mRNAsMember of ATP-dependent DExD/H box RNA helicase familyInhibits translation initiation *in vitro* upstream of 48S complex formationAccumulates in both stress granules and P-bodiesInteracts with Dcp2, Pat1, Scd6, Edc3                                                       [@bib345]; [@bib102]; [@bib62]; [@bib286]; [@bib232]
  Edc3                                              RNA-binding proteinBinds and directly stimulates Dcp2Plays major role in aggregation of P-bodies and serves as scaffold for decapping factorsNot generally required for mRNA decapping unless Dcp1/Dcp2 is limited                                                                                                                 [@bib13]; [@bib176]; [@bib73]; [@bib87]; [@bib132]
  Scd6                                              RNA-binding protein related to Edc3Genetic interaction with Edc3 and synthetic decapping defect in *edc3Δ scd6Δ* Represses translation by binding eIF4GInteracts with Dhh1, Dcp2, Pat1May be mRNA-specific decapping/translation regulatory factor                                                                                 [@bib74]; [@bib232]; Rajyaguru *et al.* (2011)
  Edc1/Edc2                                         Two small RNA-binding proteinsDirectly bind and stimulate Dcp1/Dcp2                                                                                                                                                                                                                                                                [@bib91]; [@bib268]; [@bib230]; [@bib28]
  Stm1                                              Ribosome-binding protein                                                                                                                                                                                                                                                                                                           [@bib15], [@bib16])
  Can stimulate Dhh1-dependent decapping                                                                                                                                                                                                                                                                                                                                               
                                                    Typically required only for subset of mRNAs decapping                                                                                                                                                                                                                                                                              
  Stalls 80S complex after translation initiation                                                                                                                                                                                                                                                                                                                                      
  Sbp1                                              Abundant RNA-binding protein                                                                                                                                                                                                                                                                                                       [@bib269]; Rajyaguru *et al.* (2011)
                                                    Overexpression suppresses *pat1*Δ defects by enhancing Dhh1 function                                                                                                                                                                                                                                                               
                                                    Binds eIF4G to repress translation initiation                                                                                                                                                                                                                                                                                      
  Tif51A                                            Translation initiation factor eIF5A                                                                                                                                                                                                                                                                                                [@bib344]
                                                    Specific mutations inhibit decapping                                                                                                                                                                                                                                                                                               
                                                    Mechanism is not known                                                                                                                                                                                                                                                                                                             
  Mrt4, Grc5, Sla2, Ths1                            Additional proteins affecting mRNA turnover by unknown mechanism                                                                                                                                                                                                                                                                   [@bib343]

[Dcp2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005062)'s catalytic mechanism is a typical Nudix family reaction wherein Mg++ ions coordinated by a set of glutamic acid residues promote catalysis ([@bib90]; [@bib282]). [Dcp2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005062) catalysis is promoted by the closing of the bi-lobed [Dcp2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005062) structure to create a more active enzyme and more stable substrate binding ([@bib79]; [@bib276]; [@bib103]). [Dcp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005509) is thought to enhance decapping by promoting the formation of this closed and more active structure ([@bib79]; [@bib276]). The [Dcp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005509)/[Dcp2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005062) holoenzyme or [Dcp2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005062) alone prefer longer mRNA substrates *in vitro*, which is consistent with [Dcp2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005062) containing an extended RNA-binding site and having a reaction mechanism that consists of an initial binding to the substrate followed by sliding to the cap structure ([@bib282]). However, the presence of structures near the 5′ end is unlikely to inhibit decapping *in vivo* since even mRNAs with poly(G) tracts very near their 5′ end undergo rapid decapping *in vivo* ([@bib227], [@bib228]), presumably because [Dcp2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005062) catalysis is not generally rate limiting for decapping *in vivo* (see below).

Yeast cells contain additional decapping enzymes. The [Dcs1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004260) and [Dcs2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005699) proteins are members of the HIT family of pyrophosphatases and *in vitro* appear to cleave short RNA substrates ([@bib191]). One function for [Dcs1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004260) in yeast is to cleave the m7GDP produced by decapping to m7GMP ([@bib315]), although how the m7GMP is further recycled is not known. [Dcs2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005699) can form heterodimers with [Dcs1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004260) and inhibit its activity, which occurs as cells enter diauxie ([@bib207]), although the significance of this effect is not clear. The nuclear [Rai1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003215) protein is known to function as a endonuclease that can cleave near the 5′ ends of mRNAs, and this has been suggested to function as a quality control mechanism for mRNA capping ([@bib157]).

Following decapping, mRNAs are degraded in a 5′ to 3′ direction by the [Xrn1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003141) nuclease ([@bib150]; [@bib227]), which prefers mRNA substrates with a 5′ monophosphate ([@bib283]). [Xrn1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003141) has two highly conserved domains that fold into the active region of the enzyme, which is then stabilized by interactions with additional domains ([@bib51]; [@bib158]). The active site of [Xrn1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003141) couples unwinding of duplexes to the processivity of the enzyme, which explains how it can degrade through structures without a helicase ([@bib158]). A paralog of [Xrn1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003141) is [Rat1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005574), which is typically localized to the nucleus and functions in nuclear RNA processing and/or degradation pathways (see below). However, [Rat1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005574) can substitute for [Xrn1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003141) when it is localized to the cytoplasm due to mutation, indicating that no [Xrn1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003141)-specific protein--protein interactions are required for mRNA degradation ([@bib160]). [Xrn1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003141) is inhibited by the adenosine 3′, 5′ biphosphate (pAp), which is produced by sulfate assimilation ([@bib82]), and cells can utilize this circuit to limit [Xrn1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003141) activity during various responses ([@bib22]; [@bib306]).

### Model of mRNA decapping: {#s9}

A working model for mRNA decapping has three critical steps ([Figure 2](#fig2){ref-type="fig"}). First, the 5′ cap structure must be exposed, and therefore the cytoplasmic cap-binding complex consisting of [eIF4E](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005499) and [eIF4G](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003394) needs to be lost from the mRNA. Second, the decapping enzyme must be recruited to the mRNA, which appears to be coordinated with the formation of a larger decapping complex, including the decapping enzyme, [Xrn1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003141), and several decapping activators (see below). Third, catalysis by [Dcp2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005062) occurs, leading to rapid 5′ to 3′ degradation of the mRNA. Consistent with this model, proteins enhancing decapping can function by interfering with translation initiation factors, by binding RNA and forming scaffolds for assembly of the decapping machinery, or by promoting [Dcp2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005062) catalysis. Untranslating mRNPs complexed with the decapping machinery can also aggregate into cytoplasmic RNP granules referred to as P-bodies although the specific role of these macromolecular complexes is not yet clear (see below).

![Model for mRNA decapping.](671fig2){#fig2}

### Decapping and translation initiation: {#s10}

Several observations argue that decapping is in competition with translation initiation and that decapping requires the loss of the cap-binding complex. This was first suggested since the cap structure, which is recognized for decapping, also functions in promoting translation initiation by recruiting the [eIF4E](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005499)/[eIF4G](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003394) translation initiation complex. Moreover, when translation initiation is decreased by mutations in translation initiation factors, a poor AUG context, or 5′ UTR structures, there is a concomitant increase in decapping rates ([@bib228]; [@bib181]; [@bib266]). In addition, the [eIF4E](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005499) cap-binding protein can directly inhibit decapping *in vitro* ([@bib267]). These observations argue that decapping requires the mRNP to exchange the [eIF4E](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005499)/[eIF4G](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003394) cap-binding complex for the decapping enzyme.

### Stimulation of decapping by general activators: {#s11}

Several protein factors, referred to as either decapping enhancers or activators, are known to function to stimulate the rate of decapping *in vivo* ([Table 2](#t2){ref-type="table"}). The core set of proteins affecting decapping includes [Dhh1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002319), a DEAD-box helicase, [Pat1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000673), [Edc1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003190), [Edc2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000837), [Edc3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000741), [Scd6](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006333), and the [Lsm1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003660)--7 complex. Some of these decapping activators promote decapping by inhibiting translation initiation. For example, [Dhh1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002319), a member of the DEAD family of ATPases, represses translation *in vitro*, and its overexpression in cells inhibits translation and leads to the accumulation of cytoplasmic mRNP granules ([@bib62]; [@bib287]; [@bib47]). Similarly, [Pat1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000673), [Scd6](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006333), and [Stm1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004140), which affect the decapping of some mRNAs ([@bib15]), repress translation both *in vivo* and *in vitro* ([@bib245]; [@bib232]; [@bib16]; [@bib250]).

Decapping activators can inhibit translation at different steps. For example, the [Pat1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000673), [Dhh1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002319), and [Scd6](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006333) proteins all appear to block translation before the formation of a 48S pre-initiation complex ([@bib62]; [@bib232]). For [Scd6](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006333), this translation repression appears to occur by direct binding to [eIF4G](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003394) and inhibition of the joining of the 43S complex ([@bib250]). In contrast, the [Stm1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004140) protein, which promotes decapping of a subset of yeast mRNAs ([@bib15]), inhibits translation after formation of an 80S complex, likely through direct interactions with the ribosome ([@bib16]). An unresolved issue is how inhibition of translation initiation by these factors leads to decapping. One possibility is that, by stalling initiation, it gives more time for dissociation of the translation initiation factors to allow for decapping complexes to associate with the mRNA. Alternatively, such a transition may involve an ordered exchange of factors on the mRNA, which is suggested by decapping activators, such as [Pat1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000673) and [Scd6](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006333), that can directly interact with translation factors and the decapping enzyme ([@bib232]; [@bib250]). An important area for future research is determining how mRNPs are remodeled to allow decapping complexes to form and degrade the mRNA.

A second role of decapping activators is to promote the assembly of a larger decapping complex. The core set of decapping components shows an extensive network of direct interactions as determined by protein-binding experiments with recombinant proteins and supported by co-ip and two-hybrid analyses ([@bib73]; [@bib232]). On the basis of coimmunoprecipitation (co-ip) experiments and the dependence of interactions on RNA, there appear to be two complexes that assemble on mRNAs targeted for decapping. One complex consists of the [Pat1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000673) protein, the [Lsm1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003660)--7 complex, and [Xrn1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003141) ([@bib30]; [@bib298]; [@bib297]). This complex is thought to assemble on the 3′ end of deadenylated mRNAs on the basis of its binding specificity *in vitro* ([@bib57]) and the exonuclease trimming of the 3′ end of deadenylated mRNAs in *[pat1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000673)Δ or [lsm1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003660)Δ* strains ([@bib26]; [@bib298]; [@bib138]). A second set of interacting proteins consists of the [Dcp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005509), [Dcp2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005062), [Edc3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000741), or [Scd6](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006333) and [Dhh1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002319), although whether all these factors can associate at the same time remains to be determined. Within and between these complexes, [Pat1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000673) and [Edc3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000741) appear to play important scaffolding roles and interact with many components of the decapping machinery ([@bib73]; [@bib232]).

A third role of decapping activators is to directly stimulate decapping by [Dcp2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005062). For example, the [Edc3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000741) and [Pat1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000673) proteins directly bind [Dcp2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005062) and enhance its activity in purified systems ([@bib132]; [@bib232]). Similarly, the paralogs [Edc1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003190) and [Edc2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000837), which are high-copy suppressors of temperature-sensitive alleles in [Dcp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005509) or [Dcp2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005062) ([@bib91]), bind RNA and stimulate [Dcp2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005062) either in extracts or in reconstituted systems ([@bib268]; [@bib282]). [Edc1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003190), and presumably [Edc2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000837) as well, directly bind [Dcp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005509) to stimulate the decapping enzyme by enhancing both Km and kcat of [Dcp2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005062) ([@bib28]).

Several observations suggest that [Dcp2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005062) catalysis is not generally rate limiting for decapping *in vivo*. First, conditional mutations in [Dcp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005509) or [Dcp2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005062) that compromise decapping activity *in vitro* do not significantly affect mRNA decapping rates *in vivo* ([@bib296]; [@bib91]; [@bib282]). Second, strains lacking [Edc1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003190), [Edc2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000837), and/or [Edc3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000741) do not show defects in mRNA decay rates *in vivo* unless the decapping ability of [Dcp2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005062) is reduced by mutation ([@bib91]; [@bib176]). Third, deletion of the C-terminal domain of [Pat1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000673), which stimulated [Dcp2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005062) *in vitro*, has only a marginal effect on mRNA decapping rates *in vivo* ([@bib245]; [@bib232]). Taken together, these observations suggest that, at least in mid-log growth, the rate-limiting step in decapping is the translation repression and assembly of a decapping complex on the mRNP.

Several observations suggest that [Pat1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000673) and the [Lsm1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003660)--7 complex function in an mRNP rearrangement that enhances decapping activity. First, *[lsm1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003660)Δ* strains accumulate mRNA and the decapping machinery in P-bodies, arguing that the [Lsm1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003660)--7 complex functions at a late stage in decapping after the mRNA has exited translation ([@bib277]; [@bib293]). Second, the middle and carboxy-terminal domains of [Pat1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000673) interact with themselves, and, while the C-terminal domain is sufficient to bind [Dcp2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005062) and activate decapping *in vitro*, its interaction with [Dcp2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005062) is blocked by the middle domain of [Pat1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000673) ([@bib232]). This raises the possibility that, for [Pat1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000673) to interact with [Dcp2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005062) and activate decapping catalysis, a conformational change in [Pat1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000673) between the middle and C-terminal domains is required. Strikingly, the [Lsm1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003660)--7 complex appears to interact with both the middle and the C-terminal domain of [Pat1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000673) ([@bib245]; [@bib232]). Thus, a working model is that the binding of [Pat1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000673) to the mRNA with the [Lsm1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003660)--7 complex allows for the formation of a binding site for [Dcp2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005062) in [Pat1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000673)'s C-terminal domain that is sufficient to activate catalysis.

Several other factors have been identified as promoting decapping ([@bib343]; [Table 2](#t2){ref-type="table"}). Most notably, mutations in one of the genes encoding eIF5a lead to slower decapping of mRNAs, perhaps because of alteration to translation initiation and/or translation elongation ([@bib344]; [@bib260]). The [Stm1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004140) and [Sbp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001026) proteins interact with the ribosome and [eIF4G](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003394), respectively, and thereby appear to promote the ability of [Dhh1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002319) to promote decapping ([@bib269]; [@bib15], [@bib16]; [@bib250]), although the mechanism by which these proteins stimulate [Dhh1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002319) function is unknown.

### Control of decapping: {#s12}

#### Poly(A) tails as inhibitors of decapping: {#s13}

Several observations argue that the ability of the poly(A) tail to inhibit decapping is partially mediated through the poly(A)-binding protein ([Pab1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000967)). First, it has been demonstrated in yeast that decapping occurs when the poly(A) tail length has been shortened to an oligo(A) length of ∼12 residues ([@bib72]). This is approximately the minimum length required for [Pab1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000967) binding ([@bib259]). Second, in *[pab1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000967)* mutant strains, decapping is uncoupled from deadenylation ([@bib44]; [@bib220]). In this case, intermediates in mRNA decay, trapped by inhibiting 5′ to 3′ degradation in *cis* with strong secondary structures, are produced as decapped mRNA fragments with long poly(A) species ([@bib44]). This indicates that, in the absence of [Pab1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000967), the absolute requirement for prior deadenylation before decapping is not necessary.

A second reason for decapping occurring after deadenylation is that the [Pat1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000673)/[Lsm1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003660)--7 complex prefers to bind oligoadenylated mRNAs *in vitro* ([@bib57]) and associates with mRNAs after deadenylation *in vivo* ([@bib297]). Thus, a working model is that polyadenylated mRNAs are protected by [Pab1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000967) binding and by promoting translation initiation, and deadenylated mRNAs are enhanced for decapping by the [Pat1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000673)/[Lsm1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003660)--7 complex binding and promoting translation repression and decapping ([@bib295]).

#### Control decapping on specific mRNAs: {#s14}

Differences in mRNA decapping rates appear to arise due to two features of individual mRNAs. First, since decapping is inversely related to translation initiation, features that inherently decrease translation initiation are expected to increase decapping rates. For example, the faster decapping rate of the [MFA2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005089) mRNA as compared to the [PGK1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000605) mRNA is due to a poor AUG context on the [MFA2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005089) mRNA ([@bib181]). In addition, mRNAs contain sites for sequence-specific mRNA-binding proteins that enhance decapping. For example, the binding of [Puf3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003936) to the [Cox17](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003932) mRNA enhances decapping of this mRNA following deadenylation ([@bib233]).

An important correlation is that many features that increase the decapping rate---including 3′ UTR or coding region elements, AUG context, or 5′ stem-loop structures---also increase deadenylation rate ([@bib222]; [@bib46]; [@bib228]; [@bib45]; [@bib181]; [@bib233]). This suggests that a critical aspect of controlling cytoplasmic mRNA function is an exchange of mRNAs between mRNPs complexed with translation factors and protected from decay and an mRNP associated with decay factors and having reduced translation rate and enhanced deadenylation and decapping. A key issue for future work is determining the specifics of these mRNPs and how transitions between both states occur.

Decapping of specific mRNAs can also be triggered independently of deadenylation. For example, the [Edc1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003190) mRNA is decapped without prior deadenylation, and this is due to a poly(U) tract in the 3′ UTR that sequesters the poly(A) tail and renders it nonfunctional ([@bib226]). Alternatively, in an autoregulatory loop, the [Rps28b](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004254) mRNA assembles a decapping complex through Rps28 binding to a specific stem loop in its 3′ UTR that allows decapping to proceed independently of deadenylation ([@bib13]). An unresolved issue is how many different modes of decapping exist in yeast cells and therefore how the diversity of mRNA decay rates is achieved.

Decapping can also be negatively regulated on specific mRNAs. For example, the [Khd1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000128) protein binds to and limits the decapping on the [Mtl1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003255) mRNA ([@bib212]). Since [Khd1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000128) can bind [eIF4G](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003394) and inhibit translation ([@bib238]), this may allow for the formation of a mRNP complex that is limited for translation, but protected from decapping. Since [Khd1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000128) can affect mRNA localization ([@bib133]), such a mechanism may be important in keeping mRNAs in a stable, but untranslating, state while the mRNAs localize to specific regions of the cell. This may be a common mechanism of mRNA control since multiple translation repressors that can affect decapping also bind directly to [eIF4G](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003394) and can repress translation ([@bib250]). Similarly, the [Pub1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004961) protein binds to, and stabilizes, a significant subset of yeast mRNAs, presumably by inhibiting decapping, although this has not been directly demonstrated ([@bib258]).

#### mRNA decapping and P-bodies: {#s15}

The mRNA degradation machinery can also be concentrated in specific cytoplasmic mRNP aggregates referred to as P-bodies ([@bib277]; see [Figure 2](#fig2){ref-type="fig"}). P-bodies are aggregates of untranslating mRNAs that are associated with the mRNA decapping machinery, and to a lesser extent, with the deadenylases ([@bib239]). P-bodies are proportional to the pool of untranslating mRNA associated with the decapping machinery ([@bib294]). Consistent with this view, if mRNAs are trapped in polysomes, P-bodies decrease, whereas decreases in translation initiation increase the pool of mRNAs in P-bodies ([@bib294]). Moreover, when mRNA decay is limited at the actual step of decapping or 5′ to 3′ degradation, P-bodies increase ([@bib277]; [@bib293]). mRNAs within P-bodies can return to translation ([@bib32]), and this may occur through the transition of mRNAs from P-bodies to stress granules, which are aggregates of untranslating mRNAs assocatied with translation initation factors and RNA-binding proteins (reviewed in [@bib36]). Note that the putative transfer of an mRNA from a P-body to a stress granule would correspond to an exchange of the mRNA decapping machinery for translation initiation factors ([@bib37]). This constitutes an "mRNA cycle" wherein mRNAs can exit translation either for degradation or to eventually return ([Figure 2](#fig2){ref-type="fig"}), which may play a role in the regulation of both translation and mRNA degradation ([@bib15]). Interestingly, recent genomic analyses have identified at least 400 different mRNAs, compromising a large percentage of the transcriptome, that can recycle from repression to translation upon stress relief ([@bib9]).

An unresolved issue is the role of P-body formation *per se* in the decapping of mRNAs. The aggregation of individual mRNPs into larger P-bodies is largely dependent on the YjeF domain of the [Edc3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000741) protein ([@bib73]), although P-bodies can still form to some extent on the basis of a "prion" domain on [Lsm4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000914) ([@bib73]; [@bib252]) and some [Pat1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000673)-dependent aggregation ([@bib37]). How these aggregation motifs affect mRNA decay rates is unclear. In one report, strains lacking [Edc3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000741) and/or the aggregation domain of [Lsm4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000914) did not show any changes in the decay rates of the [MFA2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005089) mRNA ([@bib73]), although in another report a strain lacking the [Lsm4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000914) aggregation motif did show a modest change in [MFA2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005089) mRNA decay rates ([@bib252]). The current simplest interpretation is that the formation of large P-body aggregates is not required for mRNA decapping but might affect the rate of decapping either in certain conditions or for subsets of mRNAs.

#### Relationship of decapping to ongoing translation elongation: {#s16}

An unresolved issue is how ongoing translation elongation affects the decapping of yeast mRNAs. Some evidence argues that decapping can be inhibited by elongating ribosomes. First, inhibition of translation elongation by chemicals such as cycloheximide or sodarin leads to decreases in the rate of decapping ([@bib18]; [@bib49]; S. Jain and R. Parker, unpublished observation). However, this could also be due to indirect effects since cycloheximide can stabilize mRNAs that are never translated as well ([@bib18]). Second, the rate of decapping of NMD substrates is proportional to the length of the ORF ([@bib43]). Moreover, in some cases, shortening the length of the ORF can lead to faster decay of specific mRNAs, although this could be due to loss of specific stabilizing sequences ([@bib139]). These results raise the possibility that mRNAs harboring elongating ribosomes have slower rates of decapping than ribosome-free mRNAs.

In contrast, several observations argue that decapping can occur while ribosomes are still associated with mRNAs. First, in the presence of cycloheximide mRNAs are seen to be shortened from their 5′ ends and degraded in a 5′ to 3′ manner to internal sites that are thought to be stalled ribosomes, although this rate is slower than normal rates of decapping ([@bib18]; [@bib49]). Similarly, mRNAs with strong stalls in translation elongation have been argued to generate mRNA fragments by decapping and 5′ to 3′ degradation to the stalled ribosomes ([@bib151]), but more recent studies argue that these mRNA fragments may be produced by an endonuclease cleavage triggered by stalled ribosomes, referred to as no-go decay (NGD; see below) (D. Muhlrad and R. Parker, unpublished data). Additional evidence for decapping occurring on mRNAs engaged in elongation is that decapped mRNAs, either in wild-type cells or in *[xrn1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003141)Δ* strains, appear to associate with polysomes, suggesting they are decapped while bound to elongating ribosomes ([@bib151]). Taken together, the best current interpretation is that decapping can occur while mRNAs are associated with ribosomes, but that ribosomes may also play a role in limiting the rates of decapping.

#### Regulation by signal transduction paths: {#s17}

Multiple signal transduction pathways impinge on mRNA decapping. First, [Ste20](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000999) has been observed to phosphorylate [Dcp2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005062) and affect its assembly into P-bodies. [Ste20](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000999) phosphorylation of [Dcp2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005062) also affects the degradation of certain mRNAs ([@bib341]). Second, [Pat1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000673) is a target of PKA, and phosphorylation of [Pat1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000673) limits its ability to assemble into P-bodies ([@bib251]), although how this affects specific protein interactions or mRNA decay is not clear. Third, when the growth regulatory Tor kinase is inhibited, the activation of the [Rim15](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001861) kinase leads to phosphorylation of the paralogous [Igo1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005101) and [Igo2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000007496) proteins, which then interact with [Dhh1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002319) and stabilize mRNAs required for entry into G0 ([@bib292]). One anticipates that other signal transduction pathways will regulate the mRNA turnover machinery. On the basis of genome-wide studies [Dhh1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002319), [Edc1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003190), [Edc3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000741), [Pop2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005335), [Ccr4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000019), [Xrn1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003141), [Dcp2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005062), and [Dcp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005509) are also known to be phosphoproteins and could be targets of such signal transduction pathways.

3′ to 5′ mRNA degradation {#s18}
=========================

The second pathway of mRNA decay following deadenylation is 3′ to 5′ degradation, which is catalyzed by the exosome and various cofactors ([Table 3](#t3){ref-type="table"}) ([@bib6]). The exosome is a multiprotein complex consisting of 10 main proteins, including six members of the RNase PH protein family and three small RNA-binding proteins ([@bib3]), which together form a ring structure analogous to bacterial PNPase ([@bib192]), and the [Rrp44](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005381)/[Dis3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005381) protein, which has both an exonuclease and endonuclease domain ([@bib184]; [@bib264]). In addition to its roles in the cytoplasm, the exosome is involved in numerous nuclear RNA processing and degradation processes (see below and reviewed in [@bib201]). In the nucleus, the exosome is also associated with [Rrp6](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005527), another 3′ to 5′ exonuclease, [Rrp47](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001123), and [Mpp6](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005307) ([@bib219]; [@bib216]), which have roles in nuclear function of the exosome (see below).

###### Exosome and associated proteins involved in 3′ to 5′ degradation of RNAs

  Component                         Features                                                                                                                                                                                                                                                                                               Reference
  --------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ---------------------------------------
  Core exosome                      Six RNasePH domain proteins (no active sites) Rrp41, Rrp42, Rrp43, Rrp45, Rrp46, Mtr3                                                                                                                                                                                                                  [@bib202]
                                    3 RNA-binding subunits (Rrp4, Rrp40, Csl4)                                                                                                                                                                                                                                                             
                                    One catalytic subunit, Rrp44, with both endo and exo active sites                                                                                                                                                                                                                                      
                                    Functions in both RNA processing and degradation in cytoplasm and nucleus                                                                                                                                                                                                                              
  Cytoplasmic cofactors                                                                                                                                                                                                                                                                                                                    
   Ski7                             Binds Csl4 subunit of coreRequired for 3′ to 5′ decay of mRNAsGTPase domain required for non-stop decayInteracts with Ski2/Ski3/Ski8 complex                                                                                                                                                           [@bib318]; [@bib324]
   Ski2/Ski3/Ski8 complex           Required for 3′ to 5′ mRNA decaySki2 is member of ATPase RNA helicase familySki8 is WD40 proteinSki3 may function as scaffold                                                                                                                                                                          [@bib6]; [@bib35]; [@bib7]; [@bib324]
  Nuclear cofactors                                                                                                                                                                                                                                                                                                                        
   Rrp6                             3′ to 5′ exonuclease of RNAseD family                                                                                                                                                                                                                                                                  [@bib38]
                                    Associated with nuclear exosome                                                                                                                                                                                                                                                                        
                                    Required for RNA processing and decay of RNAs in the nucleus                                                                                                                                                                                                                                           
                                    Functions in retention of aberrant mRNAs at sites of transcription                                                                                                                                                                                                                                     
   Rrp47 (Lrp1)                     RNA-binding protein                                                                                                                                                                                                                                                                                    [@bib38]
                                    Required for RNA processing and nuclear RNA decay                                                                                                                                                                                                                                                      
                                    Associated with nuclear exosome                                                                                                                                                                                                                                                                        
   Mpp6                             RNA-binding protein                                                                                                                                                                                                                                                                                    [@bib216]
                                    Associated with nuclear exosome                                                                                                                                                                                                                                                                        
                                    Required for RNA processing and nuclear RNA decay                                                                                                                                                                                                                                                      
   Tramp complexes (Trf4 or Trf5)   Consist of Mtr4 with 1 noncanonical poly(A) polymerase (Trf4 or Trf5) and 1 RNA-binding protein (Air1 or Air2)Required for several RNA-processing and nuclear RNA decay pathwaysCan promote processing/degradation in poly(A)-dependent and -independent manners by recruiting exosome to substrates   [@bib81]; [@bib261]; [@bib38]

Despite the similarity of the core ring domain to active exonucleases, the only active nuclease sites in the exosome appear to be present in the [Rrp44](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005381)/[Dis3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005381) protein ([@bib192]; [@bib95]). The exosome is then thought to function by the core ring structure serving as a binding platform for proteins targeting the exosome to various substrates and to channel the RNA to the active sites of [Rrp44](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005381)/[Dis3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005381) ([@bib27]).

For the degradation of cytoplasmic mRNA, the exosome requires the Ski proteins ([@bib6]; [@bib318]). The [Ski7](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005602) protein appears stably bound to the cytoplasmic exosome through the [Ski4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005176) subunit ([@bib319]). The [Ski2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004390), [Ski3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006393), and [Ski8](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003181) proteins form a separate protein complex ([@bib35]; [@bib324]). The [Ski2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004390)/3/8 complex interacts with [Ski7](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005602) ([@bib7]; [@bib324]), and this interaction, which appears to occur between [Ski7](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005602) and the [Ski3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006393) and [Ski8](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003181) proteins, is required for 3′ to 5′ degradation of mRNAs. The [Ski2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004390) protein is an ATPase of the RNA helicase family and presumably utilizes the energy of ATP hydrolysis to unwind substrates and/or dissociate bound proteins to deliver the RNA to the exosome. Interestingly, RNA processing and degradation by the nuclear exosome require the related ATPase [Mtr4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003586), suggesting that this is a general feature of exosome function (reviewed in [@bib201]).

There are several unresolved issues with regards to 3′ to 5′ degradation of mRNAs. For example, the role of the Ski complex is not well understood. Moreover, although mRNAs can have differences in their rates of 3′ to 5′ degradation ([@bib42]), the features of mRNAs that dictate different rates of 3′ to 5′ degradation are not understood. In mammalian cells, sequence-specific RNA-binding proteins can recruit the exosome directly to mRNAs, and similar events might exist in yeast cells (*e.g.*, [@bib52]). Finally, whether some mRNAs are normally degraded by the exosome or whether 3′ to 5′ degradation is the major pathway of cytoplasmic mRNA under some growth conditions is not resolved.

Other mRNA decay pathways {#s19}
=========================

Some observations imply that there will be two additional mechanisms by which yeast mRNAs are degraded. First, the vacuolar nuclease [Rny1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006044) can degrade tRNAs, rRNAs, and even small nuclear RNA (snRNAs) ([@bib302]; N. Luhtala and R. Parker, unpublished observations). Given this, one anticipates some mRNAs will also be degraded by [Rny1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006044) either during the process of autophagy or specific targeting of some mRNAs to the vacuole or because [Rny1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006044) can enter the cytosol and degrade mRNAs under some conditions ([@bib302]). A second nuclease that probably targets mRNAs during stress is [Nuc1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003744). [Nuc1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003744) is a general nuclease that is localized to the mitochondria, but during stress or in high cell densities is released to the cytosol through the mitochondrial porins and then is transported to the nucleus where it can play a role in apoptosis ([@bib39]). Interestingly, [Nuc1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003744) is also known to target the mRNAs produced by the double-stranded RNA killer virus, suggesting that it could also target some, or all, cytoplasmic mRNAs under these conditions ([@bib193]). A potential role of [Nuc1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003744) in mRNA decay is suggested by its negative genetic interactions with [Ski2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004390), -3, -7, -8, and [Xrn1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003141) ([@bib64]).

mRNA Quality Control Pathways {#s20}
=============================

Cytoplasmic quality control {#s21}
---------------------------

Several cytoplasmic quality control mechanisms degrade eukaryotic mRNAs that are defective in translation ([@bib86]). An emerging principle is that aberrant mRNAs are distinguished from the normal mRNAs by adaptor proteins that interact with the translation machinery and direct the aberrant mRNA into a degradation pathway. Key issues for each quality control pathway are the biological role, the specificity of distinguishing normal from aberrant mRNAs, and the mechanism by which mRNAs are recognized and degraded.

### Nonsense-mediated decay: {#s22}

NMD is an mRNA quality control system that degrades mRNAs with aberrant translation termination. NMD was first described as a system that degrades mutant mRNAs with premature translation termination codons ([@bib194]). However, NMD degrades a wide variety of mRNAs that have aberrant translation termination events. Such substrates include mRNAs with long 3′ UTRs that alter the relationship of the poly(A) tail to the stop codon ([@bib224]; Kebaara and Atkin 2009; [@bib75]), mRNAs with alternative translation initiation sites that that are out of frame with the main ORF and lead to premature termination ([@bib329]), mRNAs with upstream ORFs ([@bib108]; [@bib128]), pre-mRNAs that contain introns with stop codons ([@bib134]; [@bib262]), and mRNAs with frameshifts, where a proportion of the ribosomes are shifted into alternative reading frames containing premature termination codons ([@bib21]). In addition, one anticipates that errors in transcription or mis-splicing that introduce premature stop codons will generate substrates for NMD at a low level across many different genes.

Consistent with this wide range of substrates, several genomic analyses have revealed that NMD targets a wide range of different mRNAs. As such, NMD is not just a quality control system but is also utilized by cells to degrade a subset of "normal" mRNAs, particularly those involved in cell-surface dynamics and chromosome structure ([@bib187]; [@bib128]). For many of these mRNAs it is not clear why they are substrates of NMD. One possibility is that they are lacking features that specify proper translation termination and as such are targeted by NMD (see below).

Substrates for NMD are identified by the action of the interacting [Upf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004685), [Upf2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001119), and [Upf3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003304) proteins (reviewed in [@bib14]). The recognition of an mRNA by the NMD pathway has several effects on the metabolism of the mRNA. Specifically, the mRNA is targeted for enhanced deadenylation ([@bib223]; [@bib43]; [@bib218]), rapid deadenylation-independent decapping ([@bib223]), slightly increased rates of 3′ to 5′ degradation after deadenylation ([@bib43]; [@bib218]), and translation repression ([@bib225]). Consistent with NMD targeting mRNAs for translation repression, when decapping or 5′ to 3′ degradation is blocked, NMD substrates accumulate as repressed mRNAs in P-bodies in an [Upf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004685)-dependent manner ([@bib278]).

NMD has been suggested to be coupled to degradation of the nascent peptide in an [Upf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004685)-dependent manner ([@bib178]). In this manner, not only would the mRNA be degraded, but any potential dominant-negative peptides produced would also be rapidly destroyed. Interestingly, [Upf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004685) has been suggested to have ubiquitin ligase activity, and mutations that affect this activity alter the process of NMD for RNA degradation ([@bib291]), although the sites of these mutations would also be predicted to disrupt [Upf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004685) interaction with [Upf2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001119), which is known to be required for NMD ([@bib135],[@bib60]). However, how general NMD stimulated protein decay remains to be established since a peptide from a different NMD mRNA substrate shows the same decay rates in wild-type and [upf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004685)Δ cells ([@bib225]).

Transcripts appear to be targeted for the diverse effects of NMD in two steps ([Figure 3](#fig3){ref-type="fig"}). Several observations suggest that, in an initial step, [Upf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004685), which is a member of the SF1 protein superfamily of nucleic acid helicases ([@bib98]), interacts with the translation termination complex and alters the nature of translation termination (reviewed in [@bib14]). The most direct evidence is that a ribosome toeprint generated at a normal translation termination codon is distinct from the toeprint of a ribosome terminating at a premature termination codon in a manner dependent on [Upf1p](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004685) ([@bib5]). In addition, the [Upf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004685), -2, and -3 proteins co-immunoprecipitate with the eukaryotic translation termination factors [eRF1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000347) and/or [eRF3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002579) ([@bib67]; [@bib325]). Although *[upf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004685)Δ* mutants can show increased rates of stop-codon readthrough, this effect appears to be due to stabilization and increased expression in the *[upf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004685)Δ* strain of a magnesium transporter, which increases intracellular Mg++ and leads to increased miscoding of stop codons ([@bib159]). Interestingly, a defect in *[upf2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001119)Δ* and *[upf3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003304)Δ* strains in stop codon readthrough can be suppressed by overexpression of [Upf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004685), suggesting that [Upf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004685) directly affects translation, independently of [Upf2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001119) and [Upf3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003304), of mRNAs with some stop codons, perhaps by inhibiting translation initation ([@bib225]). Consistent with this view, [Upf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004685) can associate with polysomes independently of [Upf2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001119) and [Upf3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003304) ([@bib11]). The *[upf2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001119)Δ* and *[upf3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003304)Δ* strains may have decreased [Upf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004685) function since in these strains [Upf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004685) accumulates in P-bodies, and therefore the majority of [Upf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004685) may not be available to affect translation termination ([@bib278]). Moreover, because NMD substrates accumulate in P-bodies independently of [Upf2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001119) and [Upf3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003304), the simplest model is that [Upf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004685) is sufficient to repress translation of the mRNA ([@bib278]).

![Model for the nonsense-mediated decay.](671fig3){#fig3}

A second step in NMD appears to be the interaction of [Upf2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001119) and [Upf3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003304) with [Upf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004685), and this triggers the degradation of the mRNA. This conclusion is supported by the [Upf2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001119) and [Upf3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003304) independent effects of [Upf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004685) on translation readthrough and targeting of NMD substrates to P-bodies ([@bib204]; [@bib278]). [Upf3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003304) is an RNA-binding protein that is proposed to load on mRNAs in the nucleus ([@bib279]). [Upf2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001119) interacts with both [Upf3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003304) and [Upf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004685), and its binding to [Upf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004685) reduces the [Upf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004685)--RNA interaction and enhances the helicase activity of [Upf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004685) ([@bib50]). This suggests that, following translation termination altered by [Upf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004685), interaction of [Upf2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001119) with [Upf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004685) would enhance [Upf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004685) catalytic properties and lead to mRNP rearrangements that trigger mRNA degradation, possibly by rearrangements of the mRNP or by altering the fate of the terminating ribosome ([@bib115]). Consistent with that model, mutations inactivating the ATPase activity of [Upf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004685) also accumulate mRNAs in P-bodies ([@bib278]).

A key issue is how the specificity of NMD is determined. In principle, an mRNA will be targeted for NMD on the basis of the nature of translation termination (is it "aberrant" or not?) and whether [Upf2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001119)/[Upf3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003304) can influence [Upf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004685) after altered termination. Thus, the specificity of NMD is determined by factors that influence translation termination and whether [Upf2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001119)/[Upf3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003304) is associated with the mRNA after termination. One factor that contributes to proper translation termination is [Pab1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000967), which is known to interact with the translation termination factors, and, when tethered to the mRNA near a premature stop codon, can prevent NMD on that mRNA ([@bib5]). However, strains lacking [Pab1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000967), as well as poly(A)-mRNAs, still show [Upf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004685)-dependent degradation of mRNAs with premature stop codons, indicating that additional factors also contribute to NMD targeting, although whether those factors influence [Upf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004685) effects on termination or effect a downstream step in NMD is not resolved ([@bib44]; [@bib215]). Thus, a key issue is determining what other features of an mRNA influence the nature of translation termination and [Upf2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001119)/[Upf3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003304) interaction with the mRNA. Although currently controversial, one potential contribution is elements in coding regions, sometimes referred to as downstream sequence elements (reviewed in [@bib121]), that might recruit [Upf3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003304) and [Upf2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001119) to mRNAs, and, if [Upf2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001119) and [Upf3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003304) are not removed by elongating ribosomes, might lead to triggering NMD after upstream termination.

The multistep process of NMD in yeast is also revealed by the observation that 5′ proximal stop codons trigger faster mRNA degradation than stop codons farther into the ORF ([@bib194]; [@bib244]; [@bib43]). Strikingly, as judged by [Upf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004685)-promoted deadenylation, all premature stop codons are recognized as aberrant, but the position of the stop codon simply dictates differences in the actual rates of [Upf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004685)-promoted decapping ([@bib43]). Although the molecular mechanism that leads to distal stop codons leading to slower rates of decapping is not known, it does demonstrate that there are multiple steps in the targeting of an mRNA for NMD.

Additional factors can also influence the process of NMD in yeast. Both [Upf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004685) and [Upf2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001119) are phosphorylated ([@bib78]; [@bib326]), and phosphorylation of [Upf2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001119) may affect NMD ([@bib326]). In addition, strains lacking the [Ebs1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002614) protein, which is homologous to the metazoan NMD factor Smg7 and contains a 14-3-3 domain for binding phosphoproteins, show partial defects in NMD ([@bib198]). Interestingly, [Ebs1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002614) is also regulated by the NMD pathway, which might provide a feedback regulatory loop for maintaining active NMD under some conditions ([@bib104]).

### No-go decay: {#s23}

A second quality control system for mRNA translation, NGD, leads to endonucleolytic cleavage of mRNAs with strong stalls in translation elongation ([@bib85]; reviewed in detail in [@bib132]). After such cleavage, the 3′ mRNA fragment is degraded by [Xrn1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003141), and the 5′ fragment is degraded primarily by the cytoplasmic exosome ([@bib85]). No-go decay can occur at a wide range of translation elongation stalls, including strong stem loops, rare codons, polyLys or polyArg runs, sites of depurination, and possibly at frameshift sites ([@bib85]; [@bib111]; [@bib54]; [@bib179]; [@bib188]). To date, no specific mRNAs that are predominantly degraded by NGD have been identified, and the suggestion is that NGD primarily functions to degrade aberrant or damaged mRNAs, which could be produced by chemicals or ultraviolet light exposure (Y. Harigaya and R. Parker, unpublished data). The endonuclease(s) that cleaves the mRNA during NGD has not been identified.

At some translation stalls, NGD is promoted by the [Dom34](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004946) and [Hbs1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001792) proteins, which are paralogs of the translation termination factors [eRF1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000347) and [eRF3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002579) ([@bib85]). Structural analyses indicate that [Dom34](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004946) and [Hbs1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001792) fold and interact similarly to [eRF1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000347) and [eRF3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002579), respectively ([@bib186]; [@bib124]; [@bib54]; [@bib313]). Moreover, [Dom34](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004946) and [Hbs1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001792) bind the ribosome in the empty A site ([@bib17]). This similarity to translation termination complexes suggested that [Dom34](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004946) and [Hbs1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001792) function at elongation stalls to terminate translation, which has been demonstrated using reconstituted systems from both yeast and mammals ([@bib280]; [@bib246]). However, under some conditions, or at very strong translation pauses, [Hbs1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001792) and [Dom34](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004946) are not required for NGD ([@bib241]; [@bib54]; [@bib179]).

On the basis of these observations, a working model for NGD can be proposed ([Figure 4](#fig4){ref-type="fig"}). During translation elongation, the ribosome can be paused for a variety of reasons. If the A site is empty during a prolonged elongation stall, it allows for a [Dom34](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004946)/[Hbs1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001792)/GTP complex, rather than cognate aminoacyl-tRNA, to interact with the A site in the stalled ribosome, leading to dissociation of the peptide and tRNA or a peptide-tRNA conjugate, while maintaining the ribosome on the mRNA. At this stage, three events can occur. First, the mRNA can be cleaved at the vicinity of the "terminated" ribosome. Although the identity of the nuclease is unknown, it is likely to be physically associated with the stalled ribosome. Note that the mRNA cleavage could possibly occur before the release of the peptide-tRNA conjugate. Second, the ribosomes can be released by an unknown mechanism, which may or may not be similar to ribosome recycling at a regular termination codon. Release of the ribosomes is predicted to limit cleavage of the mRNA by preventing the recruitment of the nuclease. Third, the released nascent peptide or peptide tRNA-conjugate would be subject to ubiquitin-proteasome-mediated degradation, possibly in conjunction with peptide-tRNA hydrolysis.

![Model for no-go decay.](671fig4){#fig4}

### Non-stop decay: {#s24}

Another mechanism of mRNA quality control is the rapid degradation of mRNAs that do not contain translation termination codons, which is referred to as non-stop decay (NSD) ([@bib105]; [@bib319]) ([Figure 5](#fig5){ref-type="fig"}). Such mRNAs naturally occur due to use of polyadenylation sites within open reading frames, which are estimated to occur at ∼10% of the transcriptional events ([@bib319]). In addition, such non-stop mRNAs could also arise due to mutations, readthrough of stop codons due to PSI+ that limits the translation termination factor function ([@bib333]), or endonuclease cleavage sites with the open reading frame.

![Model for non-stop decay.](671fig5){#fig5}

The process of NSD appears triggered by a ribosome reaching the 3′ end of the mRNA and being unable to terminate translation. In this situation, the mRNA is rapidly degraded in a process that requires the exosome and the [Ski7](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005602), [Ski2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004390), [Ski3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006393), and [Ski8](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003181) proteins. NSD is distinguished from 3′ to 5′ decay of mRNAs by requiring the GTPase domain of [Ski7](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005602), which is similar to Ef1a and is thought to interact with the ribosome ([@bib319]). NSD is also mechanistically different from normal 3′ to 5′ decay of mRNAs in that it can utilize either endonuclease or exonuclease activity of [Rrp44](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005381), whereas 3′ to 5′ decay of normal mRNAs appears to require the exonuclease activity of [Rrp44](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005381) ([@bib263]). Given this, the prevailing model of NSD is that a stalled ribosome at the 3′ end of the mRNA is recognized by the [Ski7](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005602) protein, which then recruits the [Ski2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004390)/[Ski3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006393)/[Ski8](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003181) complex and the exosome to degrade the mRNA in a 3′ to 5′ direction. In the absence of [Ski7](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005602) or the exosome, nonstop mRNAs are subject to accelerated decapping and 5′ to 3′ degradation ([@bib153]), perhaps because of the failure to recycle terminating ribosomes for continued efficient translation initiation. An unresolved issue is how the ribosome is removed from the mRNA and if [Ski7](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005602) hydrolyzes GTP to promote its dissociation.

The peptides produced by non-stop mRNAs are also subject to rapid degradation in a proteasome-mediated manner. In this case, two different ubiquitin ligases have been proposed to function. Two reports have suggested that the [Ltn1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004861) protein, which is an E3 ubiquitin ligase that interacts with ribosomes, is required for rapid decay of the nascent peptide ([@bib334]; [@bib23]). In a second study, it has been suggested that [Not4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000870) promotes the ubiquitination and degradation of such nascent peptides ([@bib84]), although whether this is due to differences in the reporter constructs used is yet to be resolved. In either case, the rapid degradation of the nascent and aberrant polypeptide would ensure that only proteins of the proper length are produced.

The specific features of the mRNAs may affect how they become substrates for NSD or other mRNA quality control pathways. For example, while NSD mRNAs generated by poly(A) addition within the coding region require the GTPase domain of [Ski7](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005602) for their degradation, non-stop mRNAs generated by a ribozyme within the coding region do not ([@bib214]). One possibility is that this difference is due to the specific loading of proteins during nuclear polyadenylation that affect NSD in the cytosol. Alternatively, it could be that mRNAs with translated poly(A) tails are subject to a hybrid type of mRNA decay that involves aspects of both NGD and NSD. This possibility is suggested by the fact that poly(A) tracts, which encode for lysine, can stall elongating ribosomes and trigger NGD ([@bib154]; [@bib179]). An interesting area for future research will be to determine how specific types of mRNAs are recognized and targeted for these quality control systems.

Quality control of nuclear mRNA processing {#s25}
------------------------------------------

Numerous quality control systems target mRNA defective in pre-mRNA splicing, polyadenylation, or mRNA export. These nuclear quality control systems prevent the function of the aberrant mRNA by triggering nuclear degradation or by nuclear export leading to cytoplasmic degradation. In addition, aberrant or unprocessed nuclear mRNAs can also be retained within the nucleus. Nuclear retention may be important both to give time for RNA processing to be completed and to allow for a kinetically disfavored nuclear degradation pathway to degrade the RNA (see below). Examples of nuclear retention of aberrant mRNAs include the retention of mRNAs with defects in polyadenylation ([@bib145]; [@bib156]). Interestingly, these aberrant RNAs are retained in the vicinity of the gene ([@bib304]), which has the potential to have feedback effects on transcription.

### Quality control of pre-mRNA splicing: {#s26}

Several RNA degradation systems contribute to degrading unspliced or mis-spliced pre-mRNAs ([Figure 6](#fig6){ref-type="fig"}). For the [Rps22b](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004359) and [Rpl18a](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005480) pre-mRNAs, the intron contains a cleavage site for the yeast RNAseIII enzyme, [Rnt1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004852), and endonuclease cleavage within the intron reduces the pool of both pre-mRNA and the excised intron ([@bib69]). This reaction appears to occur in the nucleus due to [Rnt1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004852) being concentrated in the nucleus, and the observation that the pre-mRNA cleavage products are degraded by the nuclear [Rrp6](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005527) and [Rat1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005574) nucleases ([@bib69]). Nuclear pre-mRNA degradation has also been proposed for pre-mRNAs that fail to enter splicing or are trapped as lariat intermediates ([@bib29]).

![Mechanisms of degradation for unspliced pre-mRNAs.](671fig6){#fig6}

In contrast to nuclear degradation, multiple experiments suggest that unspliced pre-mRNA are exported to the cytoplasm and degraded. This was first suggested by the observation that the [CYH2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003071) pre-mRNA was exported to the cytoplasm and degraded by NMD ([@bib134]). Genome-wide analysis has shown that a number of pre-mRNAs with weak splicing signals are exported to the cytosol and then degraded by NMD ([@bib262]). In addition, in strains with defective splicing machinery, NMD is seen to degrade pre-mRNAs from even more genes ([@bib165]). Bioinformatics analysis suggests that this is an effective way to monitor introns since intron sequences contain an overrepresentation of translation termination signals and would tend to channel pre-mRNAs that enter translation into NMD (reviewed in [@bib96]). NMD would also be expected to degrade errors in splice site choice that lead to frameshifting during translation and thereby to premature translation termination.

Unspliced pre-mRNAs can also be degraded in the cytoplasm independently of NMD ([@bib144]), perhaps because the retained intron represses translation initiation and untranslated mRNAs in yeast tend to be rapidly deadenylated and decapped ([@bib228]).

Pre-mRNAs can also be degraded after the formation of the lariat intermediate. In this case, when the lariat intermediate is stuck---either due to mutations in the intron ([@bib144]; [@bib213]) or to errors in 5′ splice site choice or stochastic events in endogenous genes (Y. Harigaya and R. Parker, unpublished data)---the 3′ intron--exon lariat is debranched, exported to the cytoplasm, and degraded by [Xrn1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003141) or the cytoplasmic exosome. Moreover, the [Prp43](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003088) ATPase is required for this discard pathway, presumably to facilitate spliceosome disassembly, thereby allowing export ([@bib213]).

Unspliced pre-mRNAs from reporter mRNAs can also be retained at the nuclear pore by the [Mlp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001803) and [Mlp2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001411) proteins ([@bib110]), although this system appears to part of a more general quality control system for mRNA export that is not limited to pre-mRNAs ([@bib322]).

### Quality control of 3′ end generation: {#s27}

Multiple types of mutations lead to defects in mRNA 3′ end generation and polyadenylation. For example, mutations in proteins required for recognition of the polyadenylation site or the poly(A) polymerase [Pap1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001710) can alter the site of 3′ end formation and, in the case of *[pap1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001710)* alleles, lead to the production of unadenylated mRNAs ([@bib242]). Similarly, defects in mRNA export factors or in the Tho complex, which couples transcription and mRNP assembly, lead to hyperadenylation of mRNAs, perhaps due to a failure to recycle mRNP proteins to the nucleus ([@bib143]; [@bib156]; [@bib189]).

Several studies suggest that yeast mRNAs with aberrant 3′ ends are retained at the site of transcription ([@bib145]; [@bib156]). Moreover, this retention appears to be due to the absence of a proper poly(A) tail since mRNAs where the 3′ end is generated by a ribozyme are often retained ([@bib189]) unless a poly(A) tract is encoded 5′ of the site of ribozyme cleavage ([@bib89]).

The retention of aberrant mRNAs with aberrant ends requires the 3′ to 5′ exonuclease activity of the nuclear exosome and is reduced in *[rrp6](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005527)Δ* strains, or by mutations in the exonuclease active sites of [Rrp6](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005527) or [Dis3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005381)/[Rrp44](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005381) ([@bib145]; [@bib189]; [@bib304]; [@bib10]). The role of the exosome suggested that these aberrant mRNAs might be degraded in the nucleus by the nuclear exosome. However, in some cases the actual levels of mRNAs do not increase in the *[rrp6](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005527)Δ* strains, although the mRNAs are no longer nuclear retained, suggesting that the role of the exosome might be to allow retention, and not degrade, the mRNAs ([@bib145]). In contrast, in other studies it has been suggested that the exosome degrades these mRNAs since, in strains defective in the THO complex, the 3′ end of some mRNAs is reduced compared to the 5′ end, implying that some mRNAs have been degraded in a 3′ to 5′ direction ([@bib189]).

In principle, mRNAs generated in mutants with defects in 3′-end formation might be subject to three different fates and that population studies might give misleading results due to different populations behaving in different ways. For example, in export or THO mutant strains a subset of the transcripts is produced with normal 3′-end generation and poly(A) tails, and these appear to undergo normal export, deadenylation, and cytoplasmic decapping ([@bib143]; [@bib189]). A second population of mRNAs are those that are produced with either hypo- or hyperadenylated 3′ ends. Strikingly, the observable population of both hyperadenylated and hypoadenylated mRNAs is quite stable, suggesting that these mRNAs are retained within the nucleus and are stable in that state ([@bib209]; [@bib143]; [@bib257]). Finally, it may be that there is a pool of mRNAs that are recognized as aberrant and subjected to extremely rapid degradation ([@bib257]). Since these mRNAs are proposed to degrade very rapidly, it would not be possible to measure their decay rates from steady state as the steady-state pool will consist only of mRNAs that have escaped this rapid degradation. An important issue in future work is determining if such rapid degradation does occur and determining its mechanism.

Intergenic, Intragenic, Promoter-Associated, and Antisense RNAs {#s28}
===============================================================

From genome-wide analysis it is now clear that yeast cells produce numerous untraditional transcripts. Such transcripts include intergenic and intragenic transcripts (referred to as cryptic unstable transcripts, stable unannotated transcripts, or [Xrn1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003141)-sensitive unstable transcripts); antisense RNAs; transcripts associated with or overlapping promoter regions (referred to as promoter-associated RNAs); and RNAs from heterochromatin, including telomeric, centromere, and rRNA spacer regions ([@bib234]; [@bib337]; [@bib148], 2008; [@bib199]). These transcripts can be produced from bidirectional transcription from promoters of known genes ([@bib231]) or from distinct promoters ([@bib254]) and have been suggested to have a variety of functions. For example, some antisense RNAs, or their act of transcription, can play a role in modulating the expression of the corresponding sense gene via histone modification ([@bib41]; [@bib24]; [@bib149]; [@bib113]). At least in the case of the [GAL1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000224) mRNA, the degradation of an antisense RNA appears to be required for efficient induction of the corresponding sense transcript ([@bib113]). This might be a general feature of genes induced by environmental stimuli since antisense RNAs stabilized in *[xrn1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003141)Δ* and *[dcp2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005062)Δ* strains are often antisense to induced genes (Van Djik *et al.* 2011; [@bib113]), An important and unresolved future issue will be determining why degradation of this antisense RNA is required for efficient gene induction.

In other cases, transcripts that overlap the promoter, or even the ORF, can alter the transcription of the associated mRNA (*e.g.*, [@bib210]; [@bib300]; [@bib152]). Finally, since some of these RNAs are associated with ribosomes and can contain short ORFs, it seems likely that some of these RNAs encode short polypeptides ([@bib234]; [@bib301]; [@bib332]). Because many of these RNAs are most easily detected in strains defective in RNA degradation pathways, it is thought that many such RNAs are highly unstable.

This set of RNAs is subject to a variety of different and overlapping RNA degradation pathways. For example, many intergenic, antisense, and promoter-associated transcripts increase in levels and/or show increased stability in *[xrn1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003141)Δ*, *[dcp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005509)Δ*, or *[dcp2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005062)Δ* strains, suggesting that they are subject to degradation by decapping and [Xrn1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003141) action ([@bib301]; [@bib24]; [@bib316]; [@bib113]). A significant number of intergenic RNAs are also increased in strains defective in NMD, suggesting that these RNAs might enter translation and then be recognized as aberrant RNAs and degraded by NMD ([@bib301]; [@bib307]). Some of these RNAs also appear to be degraded in a mechanism dependent on RNaseP ([@bib211]).

Numerous studies have also shown that intergenic, intragenic, promoter-associated, and antisense RNAs increase in levels in strains defective in the nuclear exosome, most commonly the [Rrp6](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005527) subunit, leading to the suggestion that these RNAs are subject to nuclear 3′ to 5′ degradation ([@bib337]; [@bib71]; Thompson and Parker 2007; [@bib216]). However, examination of RNA decay rates has shown that while the steady-state levels of RNA actually increase for many RNAs in *[rrp6](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005527)Δ* strains, the actual decay rates increase and appear dependent on [Xrn1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003141) ([@bib301]), although some reports indicate an increased half-life in *[rrp6](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005527)Δ* strains ([@bib337]). One possibility is that *[rrp6](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005527)Δ* strains show increased transcription, but this model is inconsistent with nuclear run-on and RNA polymerase II chromatin immunoprecipitation experiments ([@bib337]). An alternative is that the nuclear degradation of such transcripts occurs extremely rapidly and cannot be measured at steady state, an issue that remains to be rigorously resolved in future work.

The reduction in cryptic unstable transcript and promoter-associated RNA levels by the nuclear exosome is facilitated by the TRAMP complexes ([@bib180]; [@bib337]; [@bib97]; [@bib148]; [@bib261]). The TRAMP complexes consist of one of two related RNA-binding proteins, [Air1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001341) and [Air2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002334), the [Mtr4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003586) RNA helicase, and one of two noncanonical poly(A) polymerases, [Trf4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005475) or [Trf5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005243) ([@bib180]; [@bib312]). Analogous to the situation in bacteria, the TRAMP complex can promote 3′ to 5′ degradation of RNAs by the addition of poly(A) tails to their 3′ end, which is then thought to promote the targeting of those RNAs to the exosome ([@bib162]; [@bib312]; [@bib337]). However, in some cases the TRAMP complex can also promote exosome-mediated RNA degradation independently of polyadenylation activity and may in that case serve as a scaffolding complex to recruit the exosome to the RNA ([@bib148]; [@bib257]). The TRAMP complexes also serve important roles in targeting the exosome for degradation or processing of small nucleolar RNAs (snoRNAs), snRNAs, tRNA, and other RNA species (see below).

The targeting of RNAs to the TRAMP and exosome complexes appears to be modulated in part by the [Nrd1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005195) and [Nab3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006111) RNA-binding proteins. The [Nrd1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005195) and [Nab3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006111) proteins bind to specific elements in nascent transcripts ([@bib66]; [@bib155]; [@bib336]) and can direct termination of transcription for snoRNAs, snRNAs, some mRNAs, and numerous intergenic transcripts ([@bib8]; [@bib299]; [@bib48]; [@bib256]; [@bib171]). [Nrd1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005195) and [Nab3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006111) associate with the carboxy-terminal doman of RNA polymerase II when phosphorylated at serine 5 and serine 7 ([@bib129]; [@bib320]; [@bib170]) and may act preferentially on shorter transcripts as serine 5 and 7 phosphorylation can be lost with ongoing elongation ([@bib173]; [@bib265]). [Nrd1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005195) and [Nab3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006111) then appear to recruit the exosome to degrade intergenic transcripts or to promote processing of snoRNAs and snRNAs ([@bib8]; Thiebaut *et al.* 2006; [@bib127]). This effect is not limited to RNA polymerase II transcripts as [Nab3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006111) and [Nrd1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005195) can also target RNA polymerase III transcripts for polyadenylation and degradation ([@bib336]).

Decay of tRNA, rRNAs, snRNAs, and snoRNAs {#s29}
=========================================

Most functional noncoding RNAs such as rRNAs, tRNAs, snRNAs, and snoRNAs are quite stable, although they are probably degraded at some rate even under optimal growth conditions. However, these RNAs are clearly subject to increased turnover during nutrient limitations (see below) and are also subject to a variety of quality control systems to ensure their proper biogenesis and function.

tRNAs {#s30}
-----

Three mechanisms can target tRNAs for degradation. First, when tRNAs have defects in their maturation and/or modification, pre-tRNAs can be adenylated by TRAMP complexes for targeting to the nuclear exosome ([@bib162], [@bib163]; [@bib312]). Similarly, defects in 3′-end processing of pre-tRNAs can also lead to adenylation by TRAMP complexes ([@bib346]; [@bib349]). Adenylation of defective tRNAs is thought to provide a single-stranded extension of RNA that the nuclear exosome can then load on and then degrade through the structured tRNA.

A second mechanism of tRNA decay occurs when tRNAs are defective in their modifications and/or stability of the combined acceptor and T stems. For example, in *[trm4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000120)Δ [trm8](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002360)Δ* strains, which produce undermodified tRNA\[Val(AAC)\], the tRNA\[Val(AAC)\] is degraded more rapidly ([@bib2]). This degradation utilizes the 5′ to 3′ exonucleases [Rat1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005574) and [Xrn1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003141) ([@bib56]). Moreover, mutations that weaken the stability of the combined acceptor and T stems of the tRNA increase degradation ([@bib330]). This suggests a model wherein the strength of the tRNA structure at the 5′ end dictates whether it can be subject to 5′ to 3′ degradation.

The stability of the 5′ stem loop in tRNAs can also affect whether tRNAs receive an additional CCA addition, which can promote their degradation ([@bib335]). This occurs when tRNAs have a weak acceptor stem and the first two nucleotides of the tRNA are guanosines. In this case, the tRNA appears to adopt an alternative fold whereby the CCA addition enzyme can add a second CCA, which then appears to promote degradation of the tRNA, perhaps by providing a 3′ single-stranded region for the recruitment of the exosome ([@bib335]). Strains defective in the CCA addition enzyme also produce tRNAs with shortened 3′ ends that are degraded more rapidly ([@bib1]), although the specific mechanism is not yet known. One anticipates that the stability of tRNAs will also be influenced by tRNA-binding proteins (*e.g.*, eEF1 and synthetases) that will limit nuclease accessibility.

A final mechanism of tRNA cleavage and degradation involves the nuclease [Rny1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006044). [Rny1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006044) is an RNaseT2 family member that is secreted and targeted to membrane-bound compartments, most notably the vacuole ([@bib203]). [Rny1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006044) has been shown to cleave tRNAs in the anticodon loop, at least during various stresses and high cell density ([@bib303]; [@bib302]). [Rny1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006044) may be released from membrane compartments to degrade tRNAs during stress, although it remains possible that tRNAs are also imported into the vacuole, or other membrane-bound compartment, by some type of autophagy-related process for degradation by [Rny1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006044).

rRNA decay {#s31}
----------

To date, three types of RNA degradation have been described to occur to rRNAs. First, when rRNA processing or assembly into ribosomes is altered by a variety of mutations, the defective rRNA is targeted for degradation by polyadenylation by TRAMP complexes and recruitment of the nuclear exosome (*e.g.*, [@bib4]; [@bib177]; [@bib99]; [@bib180]; [@bib163]). Polyadenylated rRNA species can also be detected in strains defective in nuclear exosome function, suggesting that a certain percentage of "normal" rRNA transcripts, either due to errors in transcription, processing, or assembly, are subject to this nuclear RNA degradation pathway.

Ribosomes that are accurately assembled but fail to function are exported to the cytoplasm and degraded by a process referred to as nonfunctional ribosomal decay. For 25S rRNAs that are defective in peptidyl transferase activity, the 60S subunit appears to be recognized as aberrant prior to assembly into 80S complexes and targeted for degradation by ubiquitination in a process dependent on the ubiquitin ligase [Rtt101](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003583) and its associated protein [Mms1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006368) ([@bib183]). The exact nuclease(s) that degrades these defective 25S RNAs is not yet known, although the exosome may have some role ([@bib61]).

For the small ribosomal subunit, mutations in the decoding site of the 18S rRNA lead to 40S complexes that can assemble into 80S complexes on the translation start site, but appear to be blocked for subsequent elongation ([@bib183]). In this case, the degradation of the defective 18S rRNAs utilizes the same [Dom34](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004946)/[Hbs1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001792) complex that is involved in the release of ribosomes stalled by defects in the mRNA (NGD; see above), which leads to degradation by the cytoplasmic exosome as well as [Xrn1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003141) ([@bib61]).

rRNAs are also subject to degradation during stress or nutrient limitations. For example, in response to oxidative stress or entry into stationary phase, the rRNAs are fragmented to some extent ([@bib221]; [@bib303]). This degradation is at least partially dependent on the [Rny1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006044) nuclease, which is concentrated in vacuoles ([@bib302]). One possibility is that these stress conditions lead to release of [Rny1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006044) from the vacuole and cleavage of cytoplasmic rRNAs ([@bib302]). Since the [Nuc1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003744) nuclease is also released from mitochondria under these conditions ([@bib39]), it might also play some role in rRNA degradation during stress. Another possibility is that rRNAs are targeted to vacuoles under these conditions by selective autophagy. Consistent with that model, based on following GFP-tagged ribosomal proteins, ribosomes have been inferred to be targeted to vacuoles during nitrogen starvation in a process referred to as ribophagy, which requires ubiquitination and de-ubiquitination ([@bib174]; [@bib235]). Ribosomes may also be targeted for degradation in the vacuole by a piecemeal microautophagy of the nucleus, wherein regions of the nucleus are directly targeted to the vacuole by invagination of the nuclear envelope into the vacuolar lumen ([@bib255]).

snRNAs/snoRNAs {#s32}
--------------

Several observations suggest that defects in snRNP or snoRNP assembly lead to degradation of these RNA species. For example, mutations in the [Naf1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005068) protein, which is required for the assembly of H/ACA snoRNPs, lead to the loss of that class of snoRNAs ([@bib100]; [@bib80]). Similarly, mutations in the SM-binding sites of yeast [U1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000007295), [U2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006478), and [U5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006495) or the telomerase RNA and [TLC1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006657) lead to decreased levels of these RNAs ([@bib161]; [@bib270]). Although effects on transcription have not been ruled out, the simplest model is that the failure to properly assemble the snoRNP/snRNPs leads to their accelerated degradation by a yet-to-be-determined degradation pathway.

Defects in [U6](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006494) snRNA biogenesis also give increased decay of RNA. For example, an internal deletion within the [U6](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006494) snRNA leads to unstable transcripts, which are adenylated and degraded by the nuclear exosome ([@bib163]). Similarly, defects in the [Lsm2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000122)--8 complex, which binds the 3′ end of the [U6](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006494) snRNA, lead to decreased levels of the [U6](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006494) snRNA ([@bib237], [@bib197]), although the mechanism of [U6](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006494) degradation in this case is not known. Taken together, these observations argue that systems exist to degrade snRNAs and snoRNAs that fail to be properly assembled into RNPs.

Degradation of RNAs in Mitochondria {#s33}
===================================

tRNAs, rRNAs, and mRNAs are also transcribed within the mitochondria of yeast cells in 13 complex transcription units. These transcripts are subject to RNA processing, including splicing of group I and group II introns, endonuclease cleavage, and 5′ and 3′ trimming. The biogenesis of mitochondrial mRNAs typically involves a 5′ endonucleolytic cleavage, often followed by 5′ to 3′ trimming of the exposed 5′ end to specific sites and a 3′ endonuclease cleavage just downstream of a so-called dodecamer element ([@bib83]). The dodecamer element is proposed to bind an unknown protein factor and may play a role in translation and/or stabilization of the mRNAs (reviewed in [@bib109]). In contrast to cytoplasmic mRNAs, mitochondrial mRNAs in yeast are not polyadenylated.

The major functional RNAse in the mitochondria mechanism is termed the mitochondrial degradasome or mtEXO and consists of a 1:1 ratio of [Dss1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004900), a member of the RNaseII family, and [Suv3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005950), a DEVH family member. Strains defective in [Suv3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005950) or [Dss1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004900) show accumulation of mitochondrial mRNAs, indicating a defect in their turnover ([@bib94]; [@bib206]). [Suv3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005950) and [Dss1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004900) mutants also accumulate excised introns, indicating that mtEXO is required for their degradation ([@bib289]). Interestingly, such strains also accumulate incompletely processed mitochondrial rRNAs, which has led to the suggestion that the mtEXO also functions in a quality control system for the degradation of rRNAs or mRNAs that are not completely processed. The activity of the mtEXO on mitochondrial mRNAs may be limited by the 3′ features of mRNAs, possibly including a factor binding the dodecamer element ([@bib217]).

The activity of mtEXO is due to the concerted action of the [Suv3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005950) helicase activity and the [Dss1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004900) nuclease in response to a RNA substrate. For example, [Suv3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005950) has intrinsic ATPase activity, but, in a complex with [Dss1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004900), the ATPase actitivy is enhanced by a single-stranded nucleic acid substrate ([@bib205]). Moreover, the helicase activity of [Suv3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005950) is dependent on [Dss1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004900) ([@bib205]). Similarly, the exonuclease activity of [Dss1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004900) is increased by [Suv3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005950) and made dependent on ATP ([@bib205]). These observations suggest a working model whereby [Suv3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005950) acts as an ATP-dependent motor to feed RNA into the active site of [Dss1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004900) ([@bib289]).

There is also a 5′ to 3′ exonuclease activity in mitochondria that is dependent on the [Pet127](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005543) protein ([@bib331]), although whether [Pet127](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005543) is actually a nuclease remains to be determined. The [Pet127](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005543)-dependent 5′ to 3′ exonuclease may also be able to stimulate and/or degrade mitochondrial RNAs since dominant mutations in, or overexpression of, [Pet127](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005543) partially suppresses the defects seen in *[suv3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005950)* or *[dss1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004900)* mutants ([@bib328]; [@bib55]). Strains lacking [Pet127](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005543) also show misregulation of some mitochondrial mRNAs, although whether this is due to misprocessing of their 5′ ends or due to disruption of normal mRNA degradation pathways is not yet clear ([@bib331]; [@bib101]).

Two additional nucleases have been localized to mitochondria but do not appear to affect RNA degradation. These include [Nuc1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003744), which is the major DNAse/RNAse in mitochondria by enzymatic activity ([@bib68]; [@bib321]), and [Rex2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004049), which is a 3′ to 5′ exonuclease that is found both in the mitochondria ([@bib130]) and in the nucleus, where it plays a role in the trimming of 5S and 5.8S rRNAs and [U4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006499) and [U5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006495) snRNA ([@bib317]). Although no clear role for these nucleases has been identified in yeast mitochondrial RNA degradation, it is notable that *[nuc1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003744)Δ* and *[rex2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004049)Δ* strains show a negative genetic interaction for growth, suggesting some degree of functional overlap ([@bib64]).

Future Perspectives {#s34}
===================

There are several areas of importance in the future study of RNA turnover in yeast cells. For example, although many RNA degradation pathways, enzymes, and cofactors have been identified, a precise understanding of their biochemical function and mechanisms of action will need further experimentation, including the development of robust *in vitro* systems for mechanistic studies. Moreover, one anticipates that there are yet-to-be-identified nucleases that play roles in RNA degradation.

It will also be important to understand how RNA degradation systems interface with other cellular processes. Although this is a general issue, three examples stand out. First, the tight inverse coupling between translation and mRNA degradation highlights that an understanding of the regulation of mRNA function will require mechanistic insight into how mRNAs transition between mRNP states capable of translation or deadenylation and mRNA decapping. A second, and related issue, is that an understanding of mRNA degradation will require a broader understanding of mRNP biogenesis, dynamics, and how the specific proteins bound to individual mRNAs act, either in isolation or in combination, to modulate translation and mRNA degradation.

A third area of interest will be in determining the relationship between mRNA degradation and transcription. This issue is of interest since several observations suggest that transcription and mRNA degradation are coupled. For example, *[dcp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005509)Δ* strains were observed to have prolonged decay rates of reporter mRNAs without a corresponding increase in steady-state levels, suggesting alterations in transcription ([@bib225]). In addition, strains lacking the decapping activator [Edc1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003190) were unable to induce new transcription during a shift in carbon source ([@bib268]). Moreover, the [Rpb4](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003676) and [Rpb7](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002812) subunits of RNA polymerase II were shown to shuttle to the cytoplasm and to affect the decay of mRNAs ([@bib195], [@bib196]; [@bib271]) in a manner coupled to their recruitment to RNA polymerase II ([@bib120]). This has led to the suggestion that transcription of new mRNAs is dependent on decay of pre-existing mRNAs in the cytosol, which would be an elegant feedback mechanism to couple mRNA biogenesis and degradation ([@bib88]). More recently, it has been suggested that the rate of mRNA degradation can be determined by the promoter ([@bib31]; [@bib308]), possibly through the loading of proteins on the nascent transcript in a promoter-dependent manner. Given these new-found connections between mRNA biogenesis and degradation, it will be important to determine how the mechanisms by which these two processes are coupled, whether this is general to most mRNAs and even other RNA classes, and the how such coupling is used by the cell to regulate gene expression in response to environmental cues.
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